NF-κB inhibitor dehydroxymethylepoxyquinomicin suppresses osteoclastogenesis and expression of NFATc1 in mouse arthritis without affecting expression of RANKL, osteoprotegerin or macrophage colony-stimulating factor

Inhibition of NF-κB is known to be effective in reducing both inflammation and bone destruction in animal models of arthritis. Our previous study demonstrated that a small cell-permeable NF-κB inhibitor, dehydroxymethylepoxyquinomicin (DHMEQ), suppresses expression of proinflammatory cytokines and a...

Descripción completa

Detalles Bibliográficos
Autores principales: Kubota, Tetsuo, Hoshino, Machiko, Aoki, Kazuhiro, Ohya, Keiichi, Komano, Yukiko, Nanki, Toshihiro, Miyasaka, Nobuyuki, Umezawa, Kazuo
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2007
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2212584/
https://www.ncbi.nlm.nih.gov/pubmed/17892600
http://dx.doi.org/10.1186/ar2298

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2212584/
https://www.ncbi.nlm.nih.gov/pubmed/17892600
http://dx.doi.org/10.1186/ar2298

Ejemplares similares